CaroGen Corporation
Company Details
Status: Private
Employees: 11-50
Location:
Hamden, Connecticut, United States
Type:
sample
Technology:
sample
sample
sample
sample
About: CaroGen Corporation is an emerging biopharmaceutical company with an entirely new vaccine platform technology developed at Yale University School of Medicine.
The Company has recently executed an exclusive license with Yale University to the replication proficient virus-like vesicle (VLV) a platform technology for the development of vaccines for worldwide commercialization.
The proprietary VLV technology which has been validated in a number of animal models including non-human primates will be employed to create new, potentially first-in-class vaccines that engage the body’s immune system to both recognize and fight off various diseases.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
CaroGen Corporation | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.